Microbubble-Controlled Delivery of Biofilm-Targeting Nanoparticles to Treat MRSA Infection

Area of Science:

• Biomedical Engineering
• Microbiology
• Gene Therapy

Background:

• Drug-resistant microorganisms, particularly methicillin-resistant Staphylococcus aureus (MRSA), pose significant healthcare challenges due to persistent infections and treatment failures.
• Bacterial biofilms contribute to chronic infections and antimicrobial resistance, necessitating innovative therapeutic strategies.

Purpose of the Study:

• To develop and validate a microbubble-controlled nanoparticle system for targeted gene silencing and elimination of MRSA biofilms in vivo.
• To assess the efficacy of biofilm-targeting nanoparticles (BTN) in combination with microbubbles (MB) for combating antibiotic-resistant bacterial infections.

Main Methods:

• Development of biofilm-targeting nanoparticles (BTN) for delivering oligonucleotides to silence key MRSA genes (icaA, ftsZ, mecA).
• In vitro validation of BTN's gene silencing and multi-targeting capabilities.
• Ex vivo assessment of BTN-MB synergy on porcine skin models.
• In vivo evaluation of MB-controlled BTN delivery in a mouse wound model infected with MRSA biofilm.

Main Results:

• BTN effectively silenced MRSA genes associated with biofilm formation, growth, and resistance in vitro.
• Combined BTN and MB demonstrated synergistic effects in biofilm removal and antimicrobial activity ex vivo.
• In vivo studies showed significant reduction in bacterial load and effective elimination of MRSA biofilms in a mouse wound model.

Conclusions:

• Microbubble-controlled nanoparticle-mediated gene silencing offers a promising strategy against challenging bacterial biofilms and antibiotic resistance.
• This physical enhancement approach combined with gene therapy presents a potent platform for future antimicrobial treatments.